ALEXANDER the not-so-great
Behaviour in the UK and elsewhere is relevant to the assessment of genuine intention to use a UK trade mark. Catherine Nursaw explains.
Services
Our services are centred around intellectual property that can be registered. We protect innovation, design, and branding across all sectors of industry, and at all stages in the supply chain.
For each IP right we offer services covering strategic advice, pre-registration searches, registrations and renewals, oppositions and dispute resolution. We handle work throughout the world, working with local colleagues in over 100 countries.
Sectors
Our attorneys specialise in one or more sectors of industry, which enables them to provide quality advice with a commercial focus.
Our patent specialists have detailed understanding of the background technology, which ensures that your patent applications are prepared with the correct scope, reducing the likelihood of challenges from third parties and objections from the patent office.
They also advise whether other forms of protection would be more appropriate. Our brand specialists work with brand managers for leading brands and their advice is commercially focussed making sure that you get the best value from your budget.
Sectors
Behaviour in the UK and elsewhere is relevant to the assessment of genuine intention to use a UK trade mark. Catherine Nursaw explains.
The UK will remain one of the most attractive jurisdictions for first patent filings, despite increased UK IPO fees from April 2018. Joshua Parsi explains.
Christopher Smith reports on a recent UK Court of Appeal case with some instructive points on patent claim construction.
There is good news for Coca-Cola in their long battle with Mitico as the General Court considers evidence from outside the EU in opposition proceedings.
Tom Bosworth highlights a recent case warning potential SPC applicants to apply for and obtain marketing authorisation promptly.
Rose Hughes considers a recent UK Court of Appeal case on the patent doctrine of “obvious to try” in the context of clinical trials.
Register for notifications
Enter your email address here to receive our monthly bulletin of IP news and developments.
"*" indicates required fields